Comparison of the antiremodeling effects of losartan and mirabegron in a rat model of uremic cardiomyopathy

Comparison of the antiremodeling effects of losartan and mirabegron in a rat model of uremic cardiomyopathy

Abstract Uremic cardiomyopathy is characterized by diastolic dysfunction (DD), left ventricular hypertrophy (LVH), and fibrosis. Angiotensin-II plays a major role in the development of uremic cardiomyopathy via nitro-oxidative and inflammatory mechanisms. In heart failure, the beta-3 adrenergic rece...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zsuzsanna Z. A. Kovács, Gergő Szűcs, Marah Freiwan, Mónika G. Kovács, Fanni M. Márványkövi, Hoa Dinh, Andrea Siska, Katalin Farkas, Ferenc Kovács, András Kriston, Péter Horváth, Bence Kővári, Bálint Gábor Cserni, Gábor Cserni, Imre Földesi, Tamás Csont, Márta Sárközy
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/3ad90176f4df4c6c9713c509cda2b33c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/3ad90176f4df4c6c9713c509cda2b33c

Ejemplares similares